Johnson C E, Lloyd C W, Mesaros J L, Rubley G J
College of Pharmacy, University of Michigan, Ann Arbor 48109-1065.
Am J Hosp Pharm. 1989 Jan;46(1):97-100.
The chemical and visual compatibility of aminophylline and verapamil hydrochloride in intravenous admixtures was evaluated. Verapamil hydrochloride injection was added to a solution of aminophylline 1.0 mg/mL in 5% dextrose injection (D5W) to yield final verapamil hydrochloride concentrations of 0.1 and 0.4 mg/mL. Each solution type was prepared in triplicate. An aliquot from each of these solutions was assayed in duplicate for theophylline and verapamil by high-performance liquid chromatography at 0, 4, 8, 12, and 24 hours after mixing. All aliquots were filtered with a 0.22-micron filter immediately before assay. At each time interval, samples were assessed for pH and inspected visually and microscopically for evidence of incompatibility. Theophylline concentrations showed less than 10% change over 24 hours in the two-drug admixtures. Less than 1% of the original verapamil concentrations remained immediately after mixing with aminophylline injection in D5W. Turbidity was readily apparent in the admixture containing verapamil hydrochloride 0.4 mg/mL; however, microscopic evaluation revealed precipitate in both solutions. Solution pH was determined to be a primary cause of precipitation. The mean pH values for the verapamil hydrochloride 0.1 and 0.4 mg/mL control solutions were 4.09 and 4.36, respectively. The mean pH of the aminophylline 1.0 mg/mL control solution was 8.35. The mean pH of the aminophylline-verapamil admixtures at verapamil hydrochloride concentrations of 0.1 and 0.4 mg/mL was 8.14 and 8.06, respectively. Verapamil hydrochloride injection in final concentrations of 0.1 and 0.4 mg/mL is incompatible with aminophylline 1.0 mg/mL in D5W.
评估了氨茶碱与盐酸维拉帕米在静脉混合液中的化学和视觉相容性。将盐酸维拉帕米注射液加入到5%葡萄糖注射液(D5W)中浓度为1.0 mg/mL的氨茶碱溶液中,使最终盐酸维拉帕米浓度分别为0.1和0.4 mg/mL。每种溶液类型均重复制备三份。在混合后0、4、8、12和24小时,通过高效液相色谱法对这些溶液中的每一份等分试样进行重复分析,测定茶碱和维拉帕米的含量。所有等分试样在分析前立即用0.22微米滤器过滤。在每个时间间隔,对样品进行pH值评估,并进行目视和显微镜检查,以寻找不相容的证据。在两种药物的混合液中,茶碱浓度在24小时内变化小于10%。在D5W中与氨茶碱注射液混合后,最初的维拉帕米浓度立即剩余不到1%。在含有0.4 mg/mL盐酸维拉帕米的混合液中,浑浊现象很明显;然而,显微镜评估显示两种溶液中均有沉淀。溶液pH值被确定为沉淀的主要原因。盐酸维拉帕米0.1和0.4 mg/mL对照溶液的平均pH值分别为4.09和4.36。1.0 mg/mL氨茶碱对照溶液的平均pH值为8.35。盐酸维拉帕米浓度为0.1和0.4 mg/mL时,氨茶碱 - 维拉帕米混合液的平均pH值分别为8.14和8.06。最终浓度为0.1和0.4 mg/mL的盐酸维拉帕米注射液与D5W中1.0 mg/mL的氨茶碱不相容。